Genetic Analysis Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 24
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Genetic Analysis General Information


Developer of bacterial gene-based clinical tests intended to offer treatment related to dysbiosis and imbalances in the bacteria in the digestive system. The company's test provides CE-marked gut microbiota analysis for testing bacterial imbalance, enabling patients with IBS (irritable bowel syndrome) and IBD (inflammatory bowel disease) to get themselves tested for microbiota and various other health conditions with ease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Primary Office
  • Kabelgata 8
  • 0580 Oslo
  • Norway
+47 483 00 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genetic Analysis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 05-Jan-2016 000 Completed Generating Revenue
4. Early Stage VC 03-Oct-2013 000 000 Completed Startup
3. Buyout/LBO 01-Jun-2012 Completed Startup
2. Early Stage VC 18-Feb-2010 Completed Startup
1. Angel (individual) Completed Startup
To view Genetic Analysis’s complete valuation and funding history, request access »

Genetic Analysis Executive Team (10)

Name Title Board Seat Contact Info
Ronny Hermansen Chief Executive Officer
Eilert Aamodt Chief Financial Officer
Finn Terje Hegge Ph.D Chief Technology Officer & Head, Operations
Anita Jusnes Chief Commercial Officer
Kathryn Baker Chairwoman
You’re viewing 5 of 10 executive team members. Get the full list »

Genetic Analysis Board Members (12)

Name Representing Role Since
Ashok Shah Genetic Analysis Board Member 000 0000
Camilla Bondesson Genetic Analysis Board Member 000 0000
Giovanni Magni Self Deputy Board Member 000 0000
Kathryn Baker Self Chairwoman 000 0000
Rune Sørum Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Genetic Analysis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genetic Analysis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biohit Corporation Minority 000 0000 000000 0
Akershus Technology Fund Venture Capital Minority 000 0000 000000 0
Televenture Venture Capital Majority 000 0000 000000 0
To view Genetic Analysis’s complete investors history, request access »